Skip to main content
George Muschler, MD, Orthopaedic Surgery, Cleveland, OH

GeorgeFMuschlerMD

Orthopaedic Surgery • Cleveland, OH

Musculoskeletal Oncology/Cancer, Orthopedic Spine Surgery

Professor of Orthopedic Surgery, Cleveland Cl College of Medicine/Case West Res Director, Regenerative Medicine Laboratory

Join to view full profile

Dr. Muschler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Muschler's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Cleveland, OH 44195
    Phone+1 216-444-5338

Summary

  • Dr. Muschler's clinical practice is specialized in adult reconstructive surgery of the hip and knee. He is exceptionally skilled in: assessment of arthritic conditions of the hip and knee, hip and knee replacement, revision of hip and knee replacement due to pain, loosening or instability; and in regenerative medicine approaches to the hip and knee preservation.
    He has an exceptional bedside manner. Patients are people, whose problems come first.

    Dr. Muschler is an Orthopaedic Surgeon and a Clinician-Scientist at the Cleveland Clinic. Building upon an MD from Northwestern, a residency at UT Southwestern, and fellowships in musculoskeletal oncology and metabolic bone disease at the Hospital for Special Surgery and Memorial Sloan Kettering in NY (1986-1988), Dr. Muschler evolved into an equally balanced clinical and research career that integrates adult reconstructive surgery, treatment of fracture non-union, and cartilage repair with research focusing on adult stem and progenitor cell biology, quantitative clinical diagnostics, aging, gender variation, tissue engineering and regenerative medicine. His laboratory has earned continuous federal funding for 18 years.

    As an institutional leader, Dr. Muschler served as Vice Chair of the Cleveland Clinic Department of Bioengineering (2004-2013); Director, Orthopaedic Research Center (2005-2013, embracing musculoskeletal research across 13 departments); and as Vice Chair, Orthopaedic and Rheumatologic Institute (2007-2013).

    As an inter-institutional leader, Dr. Muschler founded and led the translational Ohio-based Clinical Tissue Engineering Center (2005-2012). He also served as the founding Co-Director of the Armed Forces Institute of Regenerative Medicine (AFIRM) (2008-2011), funded by the Department of Defense and dedicated to the accelerated development of therapies for war injuries. In addition to 27 years of clinical trainees, Dr. Muschler has mentored over 29 research post-docs and graduate students.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Musculoskeletal Oncology, 1986 - 1988
  • The Hospital for Specal Surgery
    The Hospital for Specal SurgeryFellowship, Musculoskeletal Research and Metboloic Bone Disease, 1986 - 1988
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Orthopaedic Surgery, 1982 - 1986
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterInternship, Orthopaedic Surgery, 1981 - 1982
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1981
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignB.S., Chemistry, 1974 - 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1986 - Present
  • OH State Medical License
    OH State Medical License 1988 - 2026
  • TX State Medical License
    TX State Medical License 1982 - 1992
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2016
  • Carl Spangler Award La Trappe Creek Ecological and Historical Society, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • What Is the Price and Claimed Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis in the United States?  
    Stephanie Kha, Mitchel Ng, George F. Muschler, Michael A. Mont, The Journal of Knee Surgery
  • Evaluation of rhBMP-2/ACS/TCP-HA bone graft with addition of Bone Marrow Cells in the Canine Femoral Multi Defect Model  
    Luangphakdy, V., Shinohara, K., Pan, H., Boehm, C., Samaranska, A., Walker, E. A., Hefferan, T. E., Muschler, G. F, Eur Cell Mater, 1/1/2015
  • Modeling and Experimental Methods to Predict Oxygen Distribution in Bone Defects Following Cell Transplantation  
    Heylman CM, Santoso S, Krebs MD, Saidel GM, Alsberg E, Muschler GF, Medical & Biological Engineering & Computing, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • The Spine 
    Chapter: Spine Fusion - Principles of Bone Fusion. 
    Siemionow, C, Muschler GFEditors: Herkowitz.W.B.Saunders Company, Philadelphia, PAEdition 6th,2011
  • The Spine 
    Chapter: Spine Fusion - Principles of Bone Fusion. Chapter 26 
    Muschler GF, Takigami H, Nakamoto CEditors: Herkowitz.W.B.Saunders Company, Philadelphia, PAEdition 5th,2006
  • Orthopedic tissue engineering: basic science and practices. 
    Chapter: Intraoperative harvest and concentration of human bone marrow osteoprogenitors for enhancement of spinal fusion. Chapter 4. 
    Page 51 - 65Fleming JE, Jr., Muschler GF, Boehm C, Lieberman IH, McLain RFEditors: Goldberg VM, Caplan AI.Marcel Dekker, New York, NY2004
  • Join now to see all

Abstracts/Posters

  • Development of a Caprine Chronic Tibial Defect Model.
    Pluhar G, Nicholson A, Muschler GF, Luangphakdy V, Bechtold J, Boehm C, Carlson C, Pan H, Shinohara K, Wenke J, ORS Annual Meeting, San Antonio, TX, 1/26/2013
  • Development of Scaffolds with Tethered Epidermal Growth Factor to Improve Performance of Human Adult Stem and Progenitor Cells for Orthopaedic Tissue Engineering.
    Raut, VP, Alvarez, L A; Rivera, J A; Stockdale, L A; Boehm, C A; Patterson, T E; Griffith, L G; Muschler, G F, Orthopaedic Research Society Annual Meeting, San Fransisco, CA, 1/4/2012
  • Concentration and Selection of Osteogenic Progenitors using Magnetic Labeling based on Hyaluronan Expression for Immediate Transplantation into a Canine Femoral Multid...
    Caralla T, Joshi P, Boehm C, Hefferan T, Herrick J, Luangphakdy V, Fleury S, Yaszemski M, Zborowski M, Muschler G, TERMIS, Houston, TX, 1/11/2011
  • Join now to see all

Lectures

  • Quantitative Assays of Chondrogenic connective tissue progenitors in human knee articular cartilage – Correlation with histological grade and structure 
    San Francisco, CA - 1/22/2016
  • Optimizing soft tissue management and spacer design in caprine segmental bone defects 
    Orlando/ Kissimmee, FL - 1/15/2016
  • University of Texas at Houston 
    Cleveland Clinic Lerner College of Medicine - 1/11/2016
  • Join now to see all

Other

  • Clinical Use of Platelet Rich Plasma in Orthopaedics. 
    Boyan BD, Schwartz, Z, Patterson TE, Muschler GF, AAOS Bulletin Summer
    1/1/2007
  • The Fundamentals of Tissue Engineering – Concepts and Strategies. DVD published Slide and Audio Lecture Presentation 
    Muschler GF, Midura R, Commissioned by ORS/AAOS, AAOS for AAOS Education Program and Board Review
    1/1/2007
  • Focus on Bone Graft Substitutes for Spinal Arthrodesis: A Case-Based Monograph 
    Lauryssen C, Bauer T, Muschler GF, Bio-Continum Group, Inc.
    1/1/2006
  • Join now to see all

Press Mentions

  • To Mend Difficult Breaks, Try Porous Implants Treated with “Bone Paint”
    To Mend Difficult Breaks, Try Porous Implants Treated with “Bone Paint”May 3rd, 2021
  • New Omaha-Area Clinic Touts Stem Cells' 'Remarkable Potential' as Some Experts Urge Caution
    New Omaha-Area Clinic Touts Stem Cells' 'Remarkable Potential' as Some Experts Urge CautionJune 1st, 2018
  • Stem Cell Centers on the Rise, Claim High Efficacy for Treatment of Knee Osteoarthritis Despite Lack of Evidence
    Stem Cell Centers on the Rise, Claim High Efficacy for Treatment of Knee Osteoarthritis Despite Lack of EvidenceMarch 6th, 2018
  • Join now to see all

Grant Support

  • Cleveland Clinic Orthopaedic And Rheumatology Care -- Quality Innovation Summit 2National Institute Of Arthritis And Musculoskeletal And Skin Diseases2009
  • Extended Learning Curriculum For The Cleveland Clinic Orthopaedic &RheumatologyAgency For Healthcare Research And Quality2009
  • Optimizing Assays Of Human Stem Cells In Bone MarrowNational Institute On Aging2004–2007
  • Epidemiology Of Connective Tissue Progenitor PopulationsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2006
  • Optimizing Bone Marrow As A Bone GraftNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2005
  • Optimizing Bone Marrow As A Bone GraftNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002
  • Epidemiology Of Connective Tissue Progenitor PopulationsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002
  • Optimizing Aspirated Bone Marrow As A Bone GraftNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–1999

Dr. George Muschler, Dr. George Muschler, MD, Dr. G Muschler, Dr. George F Muschler